Table 6.

Announcement and implementation effects for top chronic and acute therapeutic classes.

Dependent variable:	Total prescriptions		Mean # of prescriptions	Total # of prescriptions
	Announce	Implement
Drug class:	(1)	(2)	(3)	(4)
Panel A: Top 8 chronic drug classes
Cardiovascular	−0.3079*	0.9655***	5.8901	120,965
	(0.173)	(0.310)
Cardiac drugs	−0.0665	0.1012	1.9975	41,022
	(0.108)	(0.185)
Diuretics	−0.2064**	−0.1903	1.7612	36,169
	(0.091)	(0.154)
Hypoglycemics	−0.2360**	0.5286**	1.7488	35,916
	(0.113)	(0.209)
Autonomic drugs	−0.0941	0.1252	1.6904	34,716
	(0.086)	(0.149)
Psychotherapeutic drugs	−0.2197**	0.1103	1.5812	32,474
	(0.104)	(0.180)
Gastrointestinal preparations	−0.2556***	0.0419	1.5326	31,474
	(0.092)	(0.156)
Antiarthritics	−0.1277*	−0.1048	1.0987	22,563
	(0.068)	(0.118)
Panel B: Top 8 acute drug classes
Analgesics	−0.1340**	0.1826	0.7640	15,690
	(0.063)	(0.112)
EENT preparations	0.0312	0.2302*	0.7469	15,339
	(0.075)	(0.119)
Antiinfectives	−0.0143	0.048	0.5549	11,395
	(0.038)	(0.062)
Antihistamines	−0.0359	−0.0187	0.4190	8,604
	(0.046)	(0.075)
Antiinfectives, miscellaneous	−0.0402	0.0826	0.2980	6,120
	(0.034)	(0.055)
Skin preparations	0.0127	0.0554	0.2546	5,228
	(0.034)	(0.052)
Muscle relaxants	−0.0091	0.0275	0.1408	2,891
	(0.020)	(0.034)
Cough and cold preparations	0.0377*	0.1265***	0.1352	2,776
	(0.021)	(0.033)

Notes:

^***p < 0.01

^**p < 0.05

^*p < 0.1.

Clustered standard errors at the person level. Columns 1 and 2 are coefficients from 16 regressions of total prescriptions for the drug class on the announcement and implementation indicators, a linear time trend, and a full set of control variables. Regressions are weighted and Medicaid beneficiaries are included. The mean number of prescriptions include zeros. MCBS 2001–2006; Ages 66–74.